Assessment of the use of hypolipidemic agents (HAs), mainly statins, in elderly subjects aged 80 years and more in Burgundy: analysis of 13,211 patients.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Archives of gerontology and geriatrics (Print)

• Publication date

  2012-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.archger.2011.06.025PMID 21868109
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Statin Prescribing in the Elderly in the Netherlands

  2010cited by this paper
• [Should all old hypertensive subjects have Mini-Mental State Examination?].

  2009cited by this paper
• Faut-il réaliser un « Mini-Mental State Examination » chez tout sujet âgé hypertendu ?

  2009cited by this paper
• Stroke in the Very Old: Incidence, Risk Factors, Clinical Features, Outcomes and Access to Resources – A 22-Year Population-Based Study

  2009cited by this paper
• Efficacy, effectiveness and real life goal attainment of statins in managing cardiovascular risk

  2009cited by this paper
• Frailty Syndrome: A Transitional State in a Dynamic Process

  2009cited by this paper
• STATINS FOR THE PRIMARY PREVENTION OF CARDIOVASCULAR EVENTS IN ELDERLY PATIENTS: A PICTURE FROM CLINICAL PRACTICE WITHOUT STRONG EVIDENCE FROM CLINICAL TRIALS

  2008influential reference
• Shift of statin use towards the elderly in 1995-2005: a nation-wide register study in Finland.

  2008influential reference
• A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance

  2008cited by this paper
• Statins for primary prevention of coronary artery disease.

  2007cited by this paper
• Are lipid-lowering guidelines evidence-based?

  2007cited by this paper
• Coronary heart disease: from a disease of middle-aged men in the late 1970s to a disease of elderly women in the 2000s.

  2006cited by this paper
• Socioeconomic Status and Stroke Incidence in the US Elderly: The Role of Risk Factors in the EPESE Study

  2006cited by this paper
• Key factors associated with the under-prescription of statins in elderly coronary heart disease patients: Results from the ELIAGE and ELICOEUR surveys.

  2006influential reference
• Statin use and survival outcomes in elderly patients with heart failure.

  2005cited by this paper
• A randomized, open-label study to evaluate the efficacy and safety of pitavastatin compared with simvastatin in Korean patients with hypercholesterolemia.

  2005cited by this paper
• Trends in prescribing and utilization of statins and other lipid lowering drugs across Europe 1997-2003.

  2005cited by this paper
• Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study).

  2004cited by this paper
• Trends in fatal and non‐fatal coronary heart disease events in Finland during 1991–2001

  2004cited by this paper
• Variations and increase in use of statins across Europe: data from administrative databases

  2004cited by this paper
• Lipid-lowering therapy with statins in high-risk elderly patients: the treatment-risk paradox.

  2004cited by this paper
• Review of dementia.

  2003cited by this paper
• Evolution of statin prescribing 1994–2001: a case of agism but not of sexism?

  2003cited by this paper
• Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors

  2003cited by this paper
• Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century.

  2003cited by this paper
• Use of statins in the secondary prevention of coronary heart disease: is treatment equitable?

  2002cited by this paper
• Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial.

  2002cited by this paper
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Commentary

  2002cited by this paper
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.

  2002cited by this paper
• Blood Pressure, Smoking and Body Mass in Relation to Mortality from Stroke and Coronary Heart Disease in the Elderly. A 10-year Follow-up in Norway

  2001cited by this paper
• Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study.

  2001cited by this paper
• Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study

  2001cited by this paper
• The design of a prospective study of Pravastatin in the Elderly at Risk (PROSPER). PROSPER Study Group. PROspective Study of Pravastatin in the Elderly at Risk.

  1999cited by this paper
• Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels.

  1998cited by this paper
• Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.

  1998cited by this paper
• Total cholesterol and risk of mortality in the oldest old.

  1997cited by this paper
• The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

  1996cited by this paper
• West of Scotland Coronary Prevention Study: identification of high-risk groups and comparison with other cardiovascular intervention trials.

  1996cited by this paper
• Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

  1995cited by this paper
• Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia

  1995cited by this paper
• Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

  1994cited by this paper

• Potentially inappropriate use of furosemide in a very elderly population: An observational study

  2017cites this paper
• Plasma zinc alpha2-glycoprotein levels correlate positively with frailty severity in female elders

  2016cites this paper
• [Management of vascular risk factors in patients older than 80].

  2014cites this paper
• Les myopathies du sujet âgé

  2014cites this paper